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Background: p21-activated kinase 1 (PAK1) is a serine/threonine kinase known to be activated by the Rho family small
GTPases and to play a key role in cytoskeletal reorganization, spine morphology and synaptic plasticity. PAK1 is also
implicated in a number of neurodevelopmental and neurodegenerative diseases, including autism, intellectual disability
and Alzheimer’s disease. However, the role of PAK1 in early brain development remains unknown.
Results: In this study, we employed genetic manipulations to investigate the role of PAK1 in the cerebral cortical
development in mice. We showed that compared to the wild type littermates, PAK1 knockout mice have a reduction in
the number of pyramidal neurons in several layers of the cerebral cortex, which is associated with a smaller pool of
neural progenitor cells and impaired neuronal migration.
Conclusion: These results suggest that PAK1 regulates cortical development by promoting the proliferation of neural
progenitor cells and facilitating the migration of these neurons to specific regions of the cortex.
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In the mammalian CNS, the cerebral cortex is a key re-
gion that dictates brain volume and overall organization.
Cortical defects are associated with many neurological
and mental disorders, including epilepsy, schizophrenia,
autism and intellectual disability [1–4]. The development
of the cerebral cortex requires a series of highly complex
and regulated events that include the amplification of ra-
dial glia cells (RGCs), generation of neurons at the sub-
ventricular zone, their migration to specified cortical
regions, and finally their differentiation and maturation
into functioning cells [3–5]. Ample studies have shown that
neurogenesis (i.e. generation of neurons) is the predomin-
ant determinant for cortical growth and organization. Thus,
a number of proteins (e.g. LIS and Nde) that are important
for mitotic cell division and survival have been shown to be* Correspondence: wei.xie@seu.edu.cn; zhengping.jia@sickkids.ca
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Similarly, proteins required for neuronal migration, particu-
larly those involved in the Reelin and CDK5 protein kinase
signal transduction pathways, are equally important for
normal cortical development [4, 5]. Exactly how these
molecules regulate neuronal migration and what cellular
processes are required remain unknown. Given the im-
portance of the actin cytoskeleton in the regulation of
cell morphology and motility, it has long been suggested
that Reelin/CDK5 may control neuronal migration through
actin reorganization [4, 5], but the molecules that are re-
sponsible for linking Reelin/CDK5 to actin remain elusive.
p21 activated kinases (PAKs) are a family of serine/threo-
nine proteins kinases known to be involved in multiple
cellular processes, including actin reorganization, cell prolif-
eration, cell morphology, motility and structural remodeling
[6–9]. In neurons, we and others have shown that PAKs are
important for neurite outgrowth, spine morphology, synap-
tic plasticity and learning and memory [9–22]. However,
most of these studies have been focused on cultured cell
lines or adult animals, and therefore whether or not PAKs
play a role in the developing brain remains unknown. How-
ever, a number of studies exist that support this possibility.is is an Open Access article distributed under the terms of the Creative
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cluding neurons [7, 21, 23]. Second, the kinase activity of
PAKs can be regulated by CDK5 and Rreelin [6, 7, 24], both
of which are critically involved in cortical development.
Third, studies in lower invertebrates indicate the involve-
ment of PAKs in neuronal development [25–28]. Finally,
PAK gene mutations are closely linked to human cortical
malformations such as microcephaly [29, 30]. Indeed, a
recent study using shRNA to knockdown PAK1 suggests
that PAK1 is required for neuronal migration, but
whether it is also involved in progenitor cell proliferation
remains unknown [13]. In this study, we used a genetic
approach to investigate the role of PAK1, the predominant
member of the PAK family expressed in the brain. We
demonstrate that PAK1 plays a key role in both progenitor
cell proliferation and neuronal migration during cerebral
cortical development.
Results
PAK1 is expressed in both mitotic and post-mitotic neurons
in the developing cortex
In order to investigate the role of PAK1 in cortical devel-
opment, we first analyzed the expression of PAK1 inFig. 1 PAK1 expression in the developing mouse neocortex. Coronal brain
DAPI (blue). a, b PAK1/DAPI staining of WT E14.5 dorsal telencephalon. CP, co
staining of WT P0 neocortical sections. e-h Magnified regions of IZ and VZ
k, l PAK1/DAPI staining of PAK KO E14.5 telencephalon showing the absen
200 μm for (i and j), 50 μm (e-h)developing brain using antibodies specific to PAK1
through immunohistochemistry. Three developmental
stages, embryonic day (E) 14.5, postnatal day (P) 0 and
P28 were examined. During early development (E14.5)
of the telencephalon (Fig. 1A, B and E-H), PAK1 was de-
tected in all the areas, of which the intermediate zone
(IZ) has the highest expression level, followed by the
cortical plate (CP) and the ventricular zone (VZ)/sub-
ventricular zone (SVZ). The high level of expression of
PAK1 in post-mitotic neurons in IZ and CP are consistent
with its demonstrated roles in regulating the morphology
and migratory properties of the neurons [13]. In addition,
strong signals were detected in the VZ/SVZ layers where
the neuronal precursor cells reside, suggesting that PAK1
may also play an important role in the proliferation and
differentiation of these cells. Similarly, at P0 (Fig. 1C, D),
PAK1 was found to be highly expressed in VZ and IZ but
a lower level was detected in the CP area. In the cerebral
cortex of the mature mouse (P28, Fig. 1I, J), PAK1 expres-
sion was detectable in all cortical layers, reflecting its roles
in synaptic transmission and plasticity. The PAK1 anti-
bodies were highly specific because no immunostaining
signals were detected in PAK1 KO mice (Fig. 1K, L). Thesections of E14.5, P0 and P28 were stained with anti-PAK1 (red) and
rtical plate; VZ, ventricular zone; IZ, intermediate zone. c, d PAK1/DAPI
areas in a and b. i, j PAK1/DAPI staining of WT P28 coronal sections.
ce of PAK1 immunostaining signals. Scale bars: 100 μm (a-d, k and l),
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early embryonic stages suggests that PAK1 may play mul-
tiple roles during cortical development.
Loss of PAK1 reduces the number of pyramidal neurons,
particularly in the upper layers of the cortex
Having established the expression pattern of PAK1 in the
developing cerebral cortex, we next investigated whether
the absence of PAK1 affects the cortical organization by
comparing PAK1 KO mice and their wild type (WT) lit-
termates. Since neuronal migration ensures that the cor-
rect number and types of neurons are deposited in the
appropriate cortical layer, we used layer specific markers
(e.g. transcription factors specifically expressed in each
layer) to examine the cortical distribution at P7. At this
time point, neurons are known to have already migrated
to their final destinations within the cortex. we found that
the overall laminar organization of the cortex is normal in
PAK1 KO mice. However, a detailed analysis of each cor-
tical layer revealed a significant reduction (about 24 %) in
the number of neurons in the superficial layer (identified
by CDP and Brn2 staining) in PAK1 KO mice (0.759 ±
0.039; n = 3 pairs of littermates, p < 0.001) compared to
their WT littermates (Fig. 2A, B and a). A significant re-
duction (about 21 %) in the number of neurons in layer V
(by Ctip2 staining) was also found in PAK1 KO mice
(Fig. 2C, D and b; KO: 0.790 ± .041; n = 3 pairs of litter-
mates, p < 0.001). Interestingly, the number of layer VI
neurons (by Tbr1 staining) remained the same between
the WT and KO mice (Fig. 2E, F and c; KO: 0.942 ± .029;
n = 3 pairs of littermates, p > 0.05). Similar results were
obtained for the P0 brains where the Brn2 and CDP posi-
tive neurons were clearly reduced in PAK1 KO mice (data
not shown). These results suggest that PAK1 is critical for
neuronal proliferation, differentiation and/or migration
during early cortical development.
PAK1 is required for normal neuronal migration to the
upper cortical layers
Cortical pyramidal neurons migrate in an “inside- out”
manner, with the early born neurons targeting to the
deep layers and the late born neurons migrating mainly
to the upper more superficial layers [4, 5]. Thus, the re-
duced neuronal number in the upper layers in PAK1 KO
mice suggests a deficit in neurons born around E14.5, in
their proliferation/differentiation/survival and/or migra-
tion. To investigate whether the reduced CDP+ cell
numbers were caused by a migration deficit, we utilized
the BrdU injection assay. The pregnant mice were injected
with BrdU at E14.5, and the number of BrdU+/CDP+ and
BrdU+/Tbr1+ (positive for both BrdU and CDP or Tbr1)
neurons of the somatosensory cortex were analyzed
at P7. As shown in Fig. 3A-H and Q, the number of
BrdU+/CDP+ neurons was clearly decreased in PAK1KO compared to WT mice (WT: 155.800 ± 11.015; KO:
114.750 ± 8.350; n = 2 pairs of littermates, p < 0.03). In
contrast, the number of BrdU+/Tbr1+ neurons was
increased in the KO mice (Fig. 3I-P and R; WT: 6.429 ±
1.288; KO: 21.400 ± 2.372; n = 2 pairs of littermates, p <
0.001). These results suggest a delayed migration of E14.5
BrdU labeled neurons. To quantify the migration path, we
divided the neocortex equally into 10 bins and analyzed
the percentage of BrdU positive cells in each bin to ob-
tain a distribution pattern of the neurons (Fig. 4). In
WT mice, approximately 66 ± 3.1 % BrdU+ cells mi-
grated to the upper layers, whereas only 50 ± 1.1 %
BrdU+ cells migrated to the same area in the KO mice.
These results together indicate that PAK1 is required
for promoting neuronal migration of the late born neu-
rons to their destinations.
PAK1 acts as a positive regulator of apical progenitor cell
proliferation
One possibility that may also result in reduced pyram-
idal neurons in PAK1 KO mice is that the KO mice
have enhanced cell death. Therefore, we examined the
degree of apoptotic cell death by performing immuno-
staining using the apoptotic cell death marker, the
active form of caspase 3, but found no differences be-
tween PAK1 KO and WT mice (Fig. 5A-C; KO: 1.032 ±
0.147; n = 3 pairs of littermates, p > 0.05), suggesting
that the cell death is not likely a significant factor con-
tributing to the reduced neuronal number in the KO
mice. Another possibility is that PAK1 KO mice may
have less neurons generated in the first place due
to impaired cell proliferation, given that PAK1 is
expressed in the proliferating VZ/ SVZ zones (Fig. 1A,
B and G, H). To address this possibility, we analyzed
the apical neuronal progenitor cells in the dorsal VZ of
the E14.5 brain using the RGC marker Pax6. An ap-
proximately 19 % decrease in the number of the apical
progenitors was observed in PAK1 KO embryos com-
pared to their WT controls (Fig. 5D-H; WT: 619.500 ±
24.592; KO: 499.750 ± 19.104; n = 4 pairs of littermates,
p < 0.001). To determine whether the reduced progeni-
tor cells were related to impaired cell division, we
again injected the pregnant mice at E14.5 with a higher
concentration of BrdU (200 mg/kg) for a brief period
of time (2 h). The proliferating progenitor cells during
the 2 h incubation period were labeled with BrdU. The
embryos were then dissected and the BrdU+ cells were
analyzed. We found a 15 % decrease in BrdU+ cells in
the dorsal VZ in PAK1 KO compared to their WT lit-
termate embryos (Fig. 6; WT: 181.182 ± 7.298; KO:
154.000 ± 8.452; n = 4 pairs of littermates, p < 0.02).
Taken together, these results indicate that PAK1 is also
an important positive regulator for cell proliferation of
the apical progenitor cells.
Fig. 2 Reduced pyramidal neurons in PAK1 KO P7 cortex. a, b Coronal brain sections from WT (a, c, e) and PAK1 KO (b, d, f) P7 mice were
stained for the late-born neuronal marker CDP (a, b) and for early-born neuronal markers, Ctip2 (c, d) and Tbr1 (e, f), respectively. a, b, c Summary
graphs of CDP, Ctip2 and Tbr1 positive neurons of WT and PAK1 KO littermates showing a significant reduction in the number of neurons in layer
II-V, but not in the Layer VI of the KO mice. ***p < 0.001. **p < 0.01. Scale bars: 100 μm
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To further investigate whether an altered cell cycle state
(active or inactive) may contribute to the reduced pool
of proliferating progenitor cells in PAK1 KO mice, weexamined the expression of Ki67, a marker for all the ac-
tive phases of the cell cycle. We injected the pregnant
mice at E13.5 with a low concentration of BrdU (50 mg/
kg) and 24 h later, the embryos were dissected and
Fig. 3 Reduced late-born pyramidal neurons in PAK1 KO P7 cortex. a–h Coronal brain sections from WT (a–d) and PAK1 KO (e–h) P7 mice were
stained for the late-born neuronal marker CDP (green) and BrdU (red) injected at E14.5, showing reduced colocalization of CDP and BrdU (yellow)
in PAK1 KO mice. i-p Coronal sections of the cortex of WT (i-l) and PAK1 KO (m-p) P7 mice stained for early-born neuronal markers, Tbr1 (green)
and BrdU (red) injected at E14.5, showing increased colocalization of Tbr1 and BrdU. d, h and (l, p) are the magnified regions from the upper and
deep layers marked by CDP and Tbr1, respectively. Arrowheads in (d, h) indicate CDP+/BrdU+ cells, in (l, p) indicate Tbr1+/BrdU+ cells. q Summary
graph of CDP+/BrdU+ cells in WT and PAK1 KO mice. r Summary graph of Tbr1+/BrdU+ cells in WT and PAK1 KO mice. *p < 0.05, ***p < 0.001. Scale
bars: 100 μm (a-c, e-g, i-k, m-o), 20 μm (d, h, l, p)
Pan et al. Molecular Brain  (2015) 8:36 Page 5 of 11stained with antibodies against BrdU and Ki67 (Fig. 7).
We found that the number of BrdU+/Ki67+ cells was
significantly reduced by 23 % in PAK1 KO embryos
compared to their WT littermate controls (Fig. 7G; WT:
0.374 ± 0.012; KO: 0.284 ± 0.013; n = 4 pairs of litter-
mates, p < 0.001). In addition, the total number of Ki67+
cells was also reduced by 32 % in the KO embryos
(Fig. 7I; WT: 480.750 ± 42.343; KO: 324.250 ± 28.142;
n = 4 pairs of littermates, p < 0.01). These results indicate
that a fewer number of cells in PAK1 KO mice were
maintained in the active phases of the cell cycle. Consist-
ent with this finding, the number of cells exiting the cell
cycle (i.e. BrdU+/Ki67- cells) was increased by 13 %
(Fig. 7H; WT: 0.626 ± 0.013; KO: 0.718 ± 0.014; n = 4pairs of littermates, p < 0.001). Therefore, PAK1 is im-
portant for maintaining the apical progenitor cells in a
proliferative state.
Discussion
Abundant evidence indicates PAK1 is a critically in-
volved in postnatal neuronal development, synaptic plas-
ticity and cognitive processes [6–9], but little is known
about its role in early brain development. In this study,
we utilized genetically altered mice lacking PAK1 to spe-
cifically probe its role in the development of the cerebral
cortex. We show that PAK1 plays a key role in ensuring
proper number and type of pyramidal neurons in the
cortex likely through maintaining an active pool of
Fig. 4 Impaired neuronal migration in PAK1 KO mice. a, b Pregnant mice were injected with BrdU at E14.5 and the brains of the WT (a) and PAK1 KO
littermates (b) were dissected at P7 and stained with anti-BrdU antibodies. c Summary graph showing a significant shift of migrating cells to the deep
layers of the cortex in PAK1 KO mice. *p < 0.05, ***p < 0.001
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migration. This conclusion is based on following lines of
evidence.
First, we show that PAK1 is expressed in all cortical
layers from E14.5 to P0. This is an important finding be-
cause although the expression of PAK1 in mature neu-
rons and adult brain are well documented, its expression
in mitotic cells during early brain development is un-
clear. Using PAK1 KO mice as a control for the specifi-
city of the PAK1 antibodies used in this study, we
conclusively demonstrate that PAK1 is expressed across
all cortical layers, including VZ/SVZ zones where the
proliferating progenitor cells reside. The widespread
neuronal expression of PAK1 suggests that PAK1 may
be involved in multiple stages of cortical neuronal devel-
opment from the birth of the neurons to their migration
to the final destination within the cortex.
Second, we demonstrate that PAK1 is required for
normal neuronal migration to the upper layers of the
cortex. In PAK1 KO mice, the distribution of BrdU posi-
tive neurons labeled at E14.5 is significantly shifted to
the deep layers, indicating that migration of these neu-
rons is impaired in the KO mice. These results are con-
sistent with an early study in rats where downregulation
of PAK1 by using viral expression of a shRNA against
PAK1 delays neuronal migration and decreases neuronal
number in layers II-IV [13]. This confirms that PAK1 is
a key regulator for proper neuronal migration in the
mammalian cortex. The mechanisms by which PAK1
regulates neuronal migration are unclear although the
shRNA study suggests that PAK1 may be important forregulating the morphology of the migratory cells [8, 13].
Therefore, it would be important to see whether the
morphology of the RGC or migratory cells are altered in
PAK1 KO mice. Given the importance of PAK1 in cyto-
skeletal regulation, it is not surprising that cell morph-
ology mediated by PAK1 may play a key role in the
migration process. In addition, how PAK1 interacts with
other molecules known to be involved in neuronal migra-
tion remains unknown. Of particular interest are CDC42,
N-cadherin and Cdk5, all of which are shown to regulate
PAK1 activity biochemically [6, 7, 24]. For example, PAK1
can be directly phosphorylated by Cdk5, a key player in
morphological dynamics of migratory neurons and cor-
tical development [24]. It is possible that PAK1 may act as
a common effector of these molecules by regulating cyto-
skeletal reorganization and neuronal morphology during
the migration and differentiation of cortical neurons.
Finally, we have revealed that PAK1 is also involved in
the proliferation of early progenitor cells. In PAK1 KO
mice, there is a smaller pool of Pax6 positive cells at
E14.5 accompanied by no changes in the degree of apop-
totic cell death. In addition, the number of cells labeled
with brief BrdU injections at E13.5 is also reduced in the
KO mice. These results are consistent with the notion
that PAK1 is important for the proliferation of the pro-
genitor cells during neurogenesis. This is an important
finding because most of the early studies have been fo-
cused on post-mitotic neurons in the adult brain [8, 9].
However, it is known that in fibroblasts cell cycle arrest
can be induced by manipulating PAK1 and that PAK1
can regulate cell cycle proteins such as cyclin D1 and D2
Fig. 5 Reduced progenitor cells in PAK1 KO mice. Coronal brain sections of WT and PAK1 KO E14.5 embryos were stained for the active form of
caspase 3 (CC3) or Pax6. a, b CC3 (red) and DAPI (blue) staining of WT (a) and PAK1 KO mice (b). c Summary graph of CC3 positive cells showing
no differences between WT and PAK1 KO mice. d-g Pax6 (red) and DAPI (blue) staining of WT (d, f) and PAK1 KO mice (e, g). h Summary graph
showing significantly decreased numbers of Pax6 positive cells PAK1 KO mice compared to their WT littermates. ***p < 0.001. Scale bars: 100 μm
Pan et al. Molecular Brain  (2015) 8:36 Page 7 of 11[31]. Therefore, the present study has extended previous
in vitro results to mouse models, establishing PAK1 as
an important in vivo regulator of neuronal proliferation
Conclusions
In summary, we show here that PAK1 KO mice are sig-
nificantly impaired in progenitor cell proliferation and
neuronal migration. These results indicate that PAK1 is
critical for cortical development by promoting proper
cell division and neuronal migration.
Methods
Mice
The generation and initial characterization of PAK1 KO
mice were described previously [10, 18]. To minimize
the effect of genetic background, all the pups and em-
bryos used in this study were PAK1 KO and their WT
littermates from heterozygous PAK1+/− breeders. All
the procedures were in accordance with animalregulations in the Hospital for Sick Children in Canada
and Southeast University in China.
Tissue processing and Immunohistochemistry
Standard procedures for brain processing and immuno-
histochemistry were described previously [32]. Briefly,
postnatal day or E14.5 pregnant mice were anaesthetized
with 10 % chloral hydrate or hypothermia and then sub-
jected to cardiac perfusion with 0.1 M phosphate-
buffered saline (PBS), followed by 4 % paraformaldehyde
(PFA) dissolved in 0.1 M PBS. Brains were removed and
post-fixed in 4 % PFA for 8–12 h for prenatal day mice
and 12–24 h for postnatal day mice, and then replaced
with 30 % sucrose dissolved in 0.1 M PBS at 4 °C until
the brains were saturated. The brains were then embed-
ded in Tissue-Tek® O.C.T. Compound and frozen by li-
quid nitrogen before being cut into coronal sections of
8 μm for prenatal day brains and 16 μm for postnatal
day brains using a Leica CM 1950 cryostat.
Fig. 6 Decreased cell proliferation in the dorsal telencephalon of PAK1 KO mice. a, b Pregnant mice were labeled with BrdU at E14.5 for 2 h and
the embryos were dissected and stained for BrdU. c, d Magnified views of the boxed regions in a and b. e Summary graph showing a significant
reduction of BrdU positive cells in the dorsal VZ in PAK1 KO embryos compared with the WT littermates. ***p < 0.001. Scale bars: 100 μm. CP, cortical
plate; LV, lateral ventricles; LGE, lateral ganglionic eminences; TH, thalamus
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in 0.1 M PBS for 5 min, permeabilized with 0.2 % Triton
X-100 dissolved in 0.1 M PBS (PBT), and then blocked
with 10 % fetal bovine serum and 0.2 % Triton X-100 dis-
solved in 0.1 M PBS for 2 h before being incubated with
primary antibodies overnight at 4 °C. Subsequently, sec-
tions were washed in 0.2 % PBT and incubated in appro-
priate secondary antibodies for 2 h at 37 °C. The primary
antibodies used in this study included: rabbit anti-Ki67
(Abcam, 1:500), rabbit anti-Tbr1 (Proteintech Group,
1:500), rabbit anti-Ctip2 (Abcam, 1:1000), rabbit anti-Pax6
(Proteintech Group, 1:1000), rabbit anti-Pak1 (Abcam,
1:1000), rabbit anti-Cleaved Caspase-3 (Cell Signaling
Technology, 1:200), rabbit anti-Brn2 (Santa Cruz, 1:50),
rabbit anti-CDP (Santa Cruz, 1:200), and rat anti-BrdU
(Abcam, 1:1000). The secondary antibodies used here
are Alexa Fluor 555 donkey anti-rabbit IgG (Invitro-
gen, 1:300), Alexa Fluor 488 donkey anti-rabbit IgG
(Invitrogen, 1:300), Alexa Fluor 488 goat anti-rat IgG
(Jackson ImmunoResearch, 1:300), Alexa Fluor 555 goatanti-rat IgG (Proteintech Group, 1:300). Nuclei were
counterstained with 4, 6-diamidino-2-phenylindole (DAPI;
Cayman Chemical).
Immunostaining images were collected using confocal
laser microscopes (LSM 700 and LSM710, Carl Zeiss) or
a light microscope (CTR 5000; Leica). The images were
then analyzed with a Zeiss Aim Image Browser software
or an Image-pro Plus software.
BrdU labeling
BrdU was obtained from Sigma-Aldrich and dissolved in
high pressure sterilized physiological saline solution at a
concentration of 10 mg/ml. For the cell division experi-
ment, the pregnant mice at E14.5 were injected intraper-
itoneally with BrdU at a concentration of 200 mg/kg for
2 h, during which time the progenitors in the S phase
were labeled. For cell cycle analysis, the pregnant mice
were intraperitoneally injected at E13.5 with BrdU at
50 mg/kg for 24 h, a time period required for cells to
complete the entire cell cycle. Following injections,
Fig. 7 Altered cell cycle state in the telencephalon of PAK1 KO embryos. a-f Pregnant mice were injected with BrdU at E13.5 for 24 h and the
embryos of the WT (a-c) and PAK1 KO (d-f) were then dissected at E14.5 and processed for immunostaining for BrdU (green), Ki67 (red) and DAPI
(blue). g, h Summary graphs of the percentages of BrdU+/Ki67+ (g) and BrdU+/Ki67- (h) cells relative to the total BrdU+ cells showing a significantly
decreased number of cells staying in the active phases of the cell cycle, as indicated by reduced BrdU+/Ki67+ cells and increased BrdU+/Ki67- cells, in
PAK1 KO mice compared to the WT littermates. (i) Summary graph showing that the number of total Ki67 positive cells was also decreased in the dorsal
telencephalon in the PAK1 KO mice compared to the WT littermates. **p < 0.01, ***p < 0.001. Scale bars: 100 μm. CP, cortical plate; VZ, ventricular zone;
SVZ, subventricular zone; IZ, intermediate zone
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described above, except that the sections were treated
with 2 M hydrochloric acid for 15 min at 45 °C for effi-
cient BrdU staining.Cell count and statistical analysis
For embryonic studies, greater than 2 independent litters
and 4 pairs of brains were used for immunostaining ex-
periments. At least 3 sections of the medial cortex from
Pan et al. Molecular Brain  (2015) 8:36 Page 10 of 11each brain were analyzed for cell counts. For each sec-
tion, an area of 300–400 μm wide with a length span-
ning either VZ/SVZ or the entire middle regions of the
E14.5 telencephalon was used.
For postnatal brain analysis, greater than 3 littermates
of each genotype were used for the experiment. And at
least 3 discontinuous coronal sections from somatosen-
sory cortex were counted. For the migration study, BrdU
+ cells were measured in vertical strips with a 400 μm
width and a length across the six-layered cortex and the
strips were equally divided into ten bins throughout the
six layers. The length of the cortex was identified by
layer specific markers and the DAPI staining.
Student’s t test was used to evaluate the data statisti-
cally, and when P < 0.05, the differences were considered
significant. And all data were presented as means ±
standard errors of the means (SEM).
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